Pfizer hooks up with Ginkgo for $331M biobucks deal on unspecified targets

Ginkgo Bioworks has snared one of its biggest partners to date. The biology biotech will work with none other than Pfizer in a drug discovery deal for RNA medicines worth $331 million in biobucks for three programs.